Form 8-K - Current report:
SEC Accession No. 0001493152-25-005103
Filing Date
2025-02-06
Accepted
2025-02-06 09:06:02
Documents
20
Period of Report
2025-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47792
2 ex5-1.htm EX-5.1 9756
3 ex10-1.htm EX-10.1 131599
4 ex10-2.htm EX-10.2 236481
5 ex99-1.htm EX-99.1 16324
6 ex5-1_002.jpg GRAPHIC 26323
7 ex5-1_001.jpg GRAPHIC 21576
8 ex99-1_001.jpg GRAPHIC 9392
  Complete submission text file 0001493152-25-005103.txt   793577

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE aztr-20250204.xsd EX-101.SCH 3018
10 XBRL LABEL FILE aztr-20250204_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE aztr-20250204_pre.xml EX-101.PRE 24167
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3672
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 25595653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)